ProductsBack/InVivoMAb anti-human VISTA

InVivoMAb anti-human VISTA

Name: InVivoMAb anti-human VISTA
SKU: BE0436_B56
Availability: BackOrder

BE0436

ApplicationsFlow Cytometry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Product group Antibodies

ReactivityHuman

Overview

Supplier
Bio X Cell
Product Name
InVivoMAb anti-human VISTA
Delivery Days Customer
7
Applications
Flow Cytometry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Certification
Research Use Only
Clonality
Monoclonal
Clone ID
GG8
Concentration
4-11 mg/ml
Estimated Purity
>95%
Host
Mouse
Isotype
IgG1
Reactivity
Human
Storage Instruction
2°C to 8°C
UNSPSC
12352203

Deng J, Li J, Sarde A, et al. Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Cancer Immunol Res. 2019,7(7):1079-1090. doi: 10.1158/2326-6066.CIR-18-0507
Read this paper
Tzeng A, Diaz-Montero CM, Rayman PA, et al. Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma. Target Oncol. 2018,13(5):599-609. doi: 10.1007/s11523-018-0595-9
Read this paper
Kuklinski LF, Yan S, Li Z, et al. VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival. Cancer Immunol Immunother. 2018,67(7):1113-1121. doi: 10.1007/s00262-018-2169-1
Read this paper
Lines JL, Sempere LF, Broughton T, et al. VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy. Cancer Immunol Res. 2014,2(6):510-7. doi: 10.1158/2326-6066.CIR-14-0072
Read this paper
Lines JL, Pantazi E, Mak J, et al. VISTA is an immune checkpoint molecule for human T cells. Cancer Res. 2014,74(7):1924-32. doi: 10.1158/0008-5472.CAN-13-1504
Read this paper